iifl-logo

Dharti Proteins Ltd Board Meeting

Add as a Preferred Source on Google
3.45
(0.88%)
Aug 24, 2015|12:00:00 AM

Dharti Proteins CORPORATE ACTIONS

05/03/2025calendar-icon
05/03/2026calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting20 Feb 20269 Feb 2026
Dharti Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the agenda for reduction in existing paid up equity share capital from 10277200 Equity shares of Rs. 10 each to 500000 Equity shares of Rs. 10 each and further allotment of 425000 Equity shares of Rs. 10 each to the Successful Resolution Applicant (SRA) Mr. Jatinbhai Ramanbhai Patel and its group of promoters 25000 equity shares of Rs. 10 each in proportion to the existing shares held by them as on record date and 50000 equity shares of Rs. 10 each shall be allotted to Goenka Business & Finance Limited Secured Financial creditors over and above the Upfront cash component as per approved resolution plan. The Board Meeting to be held on 13/02/2026 has been revised to 20/02/2026 The Board Meeting to be held on 13/02/2026 has been revised to 20/02/2026 The outcome of the meeting of Board of Directors held on Friday, February 20, 2026 has been attached herewith. (As Per BSE Announcement Dated on:20.02.2026)
Board Meeting9 Feb 20269 Feb 2026
We would like to inform that the board of directors in their meeting held on Monday, 09th February, 2026, has fixed the record date as February 13, 2026, for the purpose of Reduction of Capital pursuant to Approved Resolution Plan by Honble NCLT Order dated November 18, 2025. The outcome of the meeting has been attached herewith for your reference.
Board Meeting19 Dec 202516 Dec 2025
Devika Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/12/2025 inter alia to consider and approve 1. To approve shifting of registered office of the company within local limits of city; 2. To consider and approve the appointment of M/s. Dharti Patel & Associates (FCS 12801) Practicing Company Secretaries as the Secretarial Auditor of the Company for a period of five financial years commencing from Financial Year 2025-2026 up to Financial Year 2029-30 subject to approval of shareholders in the ensuing Annual general Meeting of the Company; 3. To consider and approve the appointment of M/s. PSG AND ASSOCIATES as the Internal Auditor of the Company; 4. To consider and approve the appointment of M/s. J.M. Patel & Bros. (Firm Registration No. 107707W) as the Tax Auditor of the Company for the Financial Year 2025-2026; 5. And such other matters; The outcome of meeting of Board of Directors held on Friday, 19th December, 2025 has been attached herewith. (As per BSE Announcement dated on: 19.12.2025)

Dharti Proteins: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.